“Research on the Motivation and Countermeasures of Financial Fraud of Listed Companies—Taking Kangmei Pharmaceutical as an Example”, FSMR, vol. 1, no. 2, pp. 1–10, Aug. 2025, doi: 10.71204/y2gzjp13.